Fennec Pharmaceuticals Inc. Common Stock (NASDAQ: FENC) last traded at $11.29, down 0.53% on the session. The quote above updates while this page is open; the figures below are drawn from Fennec Pharmaceuticals Inc. Common Stock’s own filings and are restated only when a new one is published.
Fennec Pharmaceuticals Inc. Common Stock trades on NASDAQ under the ticker FENC. Its market capitalisation is $395.91 million.
Valuation measures for Fennec Pharmaceuticals Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $395.91M |
|---|---|
| Enterprise value | $387.97M |
| Price / sales | 6.69 |
| Price / book | 9.33 |
| Beta | 1.34 |
Trailing-twelve-month figures tagged in Fennec Pharmaceuticals Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $59.22M |
|---|---|
| Net income (TTM) | -$3.25M |
| Operating margin | -1.90% |
| Return on equity | -7.66% |
| Cash | $41.25M |
Range and volume for FENC over the past 52 weeks.
| 52-week high | $13.25 |
|---|---|
| 52-week low | $5.65 |
| Volume | 189.4K |
| Average volume | 236.5K |
| Previous close | $11.35 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.